Plain language summary of the ECHELON-3 study: brentuximab vedotin combination treatment in people with diffuse large B-cell lymphoma
Future Oncology | June 19, 2025 | Volume: 21 | Issue: 16 | Pages: 1965-1983
10.1080/14796694.2025.2513219
| PMID 40536327